
DD Stock Forecast & Price Target
DD Analyst Ratings
Bulls say
DuPont de Nemours is experiencing robust growth in its Medical Packaging and Water Solutions segments, with the latter outperforming expectations and showing signs of stabilization in the Chinese market. The company anticipates significant advancements in its Electronics and Semiconductor (E&I) sector driven by the increasing demand for AI applications, projecting EBITDA growth to $3.1 billion in FY24 and $3.4 billion in FY25, which reflects increased guidance after strong second-quarter results. Furthermore, DuPont's earnings performance is outpacing its chemical peers, suggesting a resilient market position that is positioned for continued strength and recovery across various sectors leading up to its planned electronics business spin-off by the end of 2025.
Bears say
DuPont de Nemours is projected to experience a sequential decline in EBITDA, guiding to approximately $790 million for 4Q, which reflects challenges due to temporary volume disruptions from new Chinese semiconductor capacity. The company's performance in the Water & Protection segment has been hindered by declining safety solutions sales and weakness in residential construction, coupled with mixed results in the industrial market, particularly with ongoing destocking in Kalrez products. Overall, delays in synergy realization, continued weakness in the electronics sector, and a sluggish recovery in China contribute to a negative outlook for the company moving forward.
This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares